The vice president and lead of IQVIA's Market Access Center of Excellence says fewer drugs are hitting the $100 million mark ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

IQVIA™ (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence ...

Leadership transition and strategic growth initiatives mark the next phase of Comac Medical's development under EdgeCap Partners. SOFIA, Bulgaria, April 28, 2025 /PRNewswire/ -- Comac Medical ...

Comac Medical, a leading full-service Contract Research Organization (CRO) in Central and Eastern Europe, announced today the ...

In subgroup analyses, increases in discontinuation of inhaled steroid therapy were greater among kids ages 5 years and ...

Fintel reports that on April 25, 2025, HSBC downgraded their outlook for IQVIA Holdings (NYSE:IQV) from Buy to Hold. Analyst ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $227.67, ...

In 2024, the U.S. healthcare industry spent $6.1 billion on Pfizer’s COVID-19 therapy Paxlovid, a 6,922.8% increase from 2023 expenditure data, according to a recent study. The research, published ...

Nordic Pharma, a subsidiary of Nordic Group B.V., announced a partnership with Harrow, a leading North American eyecare ...

HSBC (LON:HSBA) has reshuffled its ratings across the MedTech and Life Sciences sector, upgrading Siemens Healthineers AG (ETR:SHLG) and Sonova (SIX:SOON) to Buy while cutting Align Technology (NASDAQ ...

HSBC analyst Sidharth Sahoo downgraded Iqvia (IQV) to Hold from Buy with a price target of $160, down from $260. The firm adjusted ratings in ...